Molecular Phylogenetics of Transmitted Drug Resistance in Newly Diagnosed HIV Type 1 Individuals in Denmark, a Nation-Wide Study
- 1 December 2011
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 27 (12) , 1283-1290
Abstract
Highly active antiretroviral treatment is compromised by viral resistance mutations. Transmitted drug resistance (TDR) is therefore monitored closely, but follow-up studies of these patients are limited. Virus from 1405 individuals diagnosed with HIV-1 in Denmark between 2001 and 2009 was analyzed for TDR, and molecular-epidemiological links and progression of the infection were described based on data from standardized questionnaires, the prospective Danish HIV Cohort Study, and by phylogenetic analysis. Eighty-five individuals were found to be infected with virus harboring mutations resulting in a prevalence of 6.1%, with no changes over time. The main resistance mutations were nucleoside reverse transcriptase inhibitor (NRTI) mutation 215 revertants, as well as nonnucleoside reverse transcriptase inhibitor (NNRTI) mutation 103N/S and protease inhibitor (PI) mutations 90M and 85V. Phylogenetic analysis confirmed 12 transmission chains involving 37 TDR individuals. Of these 21 were also documented epidemiologically. The virus included in the transmission chain carried similar resistance mutations to the TDR index case, whereas controls chains from index cases without TDR were generally without resistance mutations. We observed no difference in progression of the infection between individuals infected with TDR and individuals infected with wild-type HIV-1. The prevalence of TDR is low in Denmark and transmission of dual-drug-resistant HIV-1 is infrequent. The TDR isolates were shown to originate from local patients failing therapy.Keywords
This publication has 28 references indexed in Scilit:
- Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide studyBritish Journal of Clinical Pharmacology, 2011
- Transmission of HIV‐1 Drug‐Resistant Variants: Prevalence and Effect on Treatment OutcomeClinical Infectious Diseases, 2010
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- Transmission networks of drug resistance acquired in primary/early stage HIV infectionAIDS, 2008
- Transmission Cluster of Multiclass Highly Drug-Resistant HIV-1 Among 9 Men Who Have Sex With Men in Seattle/King County, WA, 2005-2007JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- The Incidence Rate of HIV Type-1 drug Resistance in Patients on Antiretroviral Therapy: A Nationwide Population-Based Danish Cohort Study 1999–2005Antiviral Therapy, 2008
- Cohort Profile: The Danish HIV Cohort StudyInternational Journal of Epidemiology, 2008
- Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment EfficacyPLOS Medicine, 2008
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Identification of a Transmission Chain of HIV Type 1 Containing Drug Resistance-Associated MutationsAIDS Research and Human Retroviruses, 2003